Pennant Group Inc logo

Pennant Group Inc(PNTG)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
4-STAR RATING
SELL
SELL for 5 days
PROFIT SINCE LAST BUY
-14.64% ▼
LAST CLOSE
$36.07
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for PNTG

11/13/2026: PNTG (4-star) is a SELL. SELL for 5 days. Simulated Profits (-14.64%). Updated daily EoD!

The Pennant Group, Inc. is a healthcare services company focused on home health, hospice, and senior living. The company is known for its decentralized operating model, which integrates these services in local clusters to improve efficiency and care coordination. A primary investment story is the demographic-driven demand for aging-in-place solutions and the potential for steady expansion through targeted acquisitions. Investors should be aware of risks including federal reimbursement changes, intense competition for clinical staff, and geographic concentration. The stock may best suit growth-oriented investors who can tolerate the volatility associated with small-cap healthcare stocks, while key developments to monitor include labor cost trends and regulatory updates.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company is expanding its service footprint in a demographic-driven sector.
Momentum investorMixed fitMomentum is conditional on positive trends in regulatory outcomes and operational performance.
Value investorMixed fitValuation is often tied to long-term growth prospects rather than current cash yield.
Dividend investorWeak fitThe company does not pay dividends, focusing on reinvestment.
Low-risk investorWeak fitHealthcare regulatory exposure and operational volatility create higher risk profiles.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highSmall-cap healthcare stocks can see significant price swings based on earnings news.
Valuation riskMediumMarket expectations for growth must be met to sustain current valuation multiples.
Competition risk (healthcare services)HighFragmented markets mean intense local competition for patients and staff.
Business qualityMediumThe model depends on consistent operational execution at the local agency level.
Dividend incomeLow / noneInvestors should not rely on PNTG for regular income streams.
Execution riskMedium / highSuccessful integration of acquired agencies is crucial for scaling the business.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.26B USD
Price to earnings Ratio 35.55
1Y Target Price 48
Price to earnings Ratio 35.55
1Y Target Price 48
Volume (30-day avg) 415.4K shares
Beta 1.3
52 Weeks Range 24.92 - 44.24
Updated Date 11/13/2026
52 Weeks Range 24.92 - 44.24
Updated Date 11/13/2026
Dividends yield (FY) -
Basic EPS (TTM) 1.01

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 89.36%
Avg. Invested days 56
Today’s Advisory SELL
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
PNTG receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
PNTG has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and strong ownership. In FY2025 versus FY2024, solid earnings growth (+31.1%) and strong revenue growth (+36.3%) are partially offset by soft cash generation (FCF margin 2.8%), soft profitability (net margin 3.1%).

Financial Health Rating

★★★★★
PNTG's financial health is supported by solid cash strength, including free-cash-flow generation (2.8% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is PNTG's strongest growth driver at +36.3% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+31.1%, solid) is also solid, while free-cash-flow growth (-13.2%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 95.7% and approximately 95.1% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 5.06% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 8.44%
Van Berkom and Associates Inc 6.17%
Wasatch Advisors LP 5.33%
Turtle Creek Asset Management Inc. 4.89%
Vanguard Capital Management, LLC 4.22%

Unit Economics (Per $1K Revenue)

★★★★★
PNTG generates approximately $129 of gross profit, $54 of operating income, and $28 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 2-star rating, with soft cash conversion and soft capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 26.00%

Quantitative Style Profile

★★★★★
PNTG has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Home Health and HospiceMedicare and private insurance billings for clinical and palliative care services.Revenue comes from providing essential, reimbursed healthcare services to patients in their homes.
Senior LivingMonthly service fees for residential care and assisted living facility residents.Revenue is generated from private pay and insurance-backed housing and support services for seniors.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-04
When After Market
Estimate 0.28
Actual 0.28

Profitability

Profit Margin 3.05%
Operating Margin (TTM) 6.11%

Management Effectiveness

Return on Assets (TTM) 5%
Return on Equity (TTM) 11.18%

Valuation

Trailing PE 35.55
Forward PE 23.31
Enterprise Value 1.76B
Price to Sales(TTM) 1.07
Enterprise Value 1.76B
Price to Sales(TTM) 1.07
Enterprise Value to Revenue 1.5
Enterprise Value to EBITDA 21.37
Shares Outstanding 35.13M
Shares Floating 33.40M
Shares Outstanding 35.13M
Shares Floating 33.40M
Percent Insiders 5.06
Percent Institutions 95.73

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.